You are here
Clinical Trials: Stroke and Related
Each Clinical Trial will open in a new browser window or tab.
Conditions: Stroke; Hemiparesis
Intervention: Device: IpsiHand Treatment
Sponsors: Columbia University; Neurolutions, Inc.
Not yet recruiting
Intervention: Device: IpsiHand Treatment
Sponsors: Columbia University; Neurolutions, Inc.
Not yet recruiting
Condition: Acute Ischemic Stroke
Intervention: Biological: UMC119-06
Sponsor: Meridigen Biotech Co., Ltd.
Not yet recruiting
Intervention: Biological: UMC119-06
Sponsor: Meridigen Biotech Co., Ltd.
Not yet recruiting
Conditions: Infarction, Middle Cerebral Artery; Infarction, Anterior Cerebral Artery; Cerebral Infarction; Stroke, Ischemic; Acute Stroke
Interventions: Biological: human umbilical cord mesenchymal stem cells; Biological: Placebo; Other: standardized treatment
Sponsor: Shanghai East Hospital
Recruiting
Interventions: Biological: human umbilical cord mesenchymal stem cells; Biological: Placebo; Other: standardized treatment
Sponsor: Shanghai East Hospital
Recruiting
Condition: Chronic Stroke
Intervention: Drug: GXNPC1
Sponsor: Gwo Xi Stem Cell Applied Technology Co., Ltd.
Not yet recruiting
Intervention: Drug: GXNPC1
Sponsor: Gwo Xi Stem Cell Applied Technology Co., Ltd.
Not yet recruiting
Conditions: Cerebral Ischemia; Cerebral Infarction; Stroke, Acute
Interventions: Drug: Normal Saline along with standard treatment; Drug: PMZ-1620 (sovateltide) along with standard treatment
Sponsor: Pharmazz, Inc.
Not yet recruiting
Interventions: Drug: Normal Saline along with standard treatment; Drug: PMZ-1620 (sovateltide) along with standard treatment
Sponsor: Pharmazz, Inc.
Not yet recruiting
Conditions: Stroke; Umbilical Cord Blood; Erythropoietin; Safety; Treatment Outcome
Interventions: Drug: Umbilical cord blood infusion; Drug: Erythropoietin injection; Drug: Placebo umbilical cord blood infusion; Drug: Placebo erythropoietin injection; Procedure: Active rehabilitation
Sponsors: Bundang CHA Hospital; Korea Evaluation Institute of Industrial Technology
Recruiting
Interventions: Drug: Umbilical cord blood infusion; Drug: Erythropoietin injection; Drug: Placebo umbilical cord blood infusion; Drug: Placebo erythropoietin injection; Procedure: Active rehabilitation
Sponsors: Bundang CHA Hospital; Korea Evaluation Institute of Industrial Technology
Recruiting
Conditions: Subcortical Vascular Dementia; Cerebral Small Vessel Diseases
Interventions: Drug: NBP; Drug: Placebos
Sponsor: Tianjin Medical University General Hospital
Recruiting
Interventions: Drug: NBP; Drug: Placebos
Sponsor: Tianjin Medical University General Hospital
Recruiting
Condition: Acute Ischemic Stroke
Intervention: Biological: HPC, Cord Blood
Sponsor: BHI Therapeutic Sciences
Not yet recruiting
Intervention: Biological: HPC, Cord Blood
Sponsor: BHI Therapeutic Sciences
Not yet recruiting
Condition: Stroke, Ischemic
Intervention: Biological: Induction of neural stem cells
Sponsor: Allife Medical Science and Technology Co., Ltd.
Not yet recruiting
Intervention: Biological: Induction of neural stem cells
Sponsor: Allife Medical Science and Technology Co., Ltd.
Not yet recruiting
Conditions: Alzheimer Disease; Alzheimer Dementia; Vascular Dementia; Lewy Body Disease; Lewy Body Dementia With Behavioral Disturbance (Disorder); Dementia, Mixed; Parkinson-Dementia Syndrome; Chronic Traumatic Encephalopathy; Huntington's Dementia; Wernicke Korsakoff Syndrome; Traumatic Brain Injury; Dementia, Multi-Infarct; Autism; Autism Spectrum Disorder; Autistic Behavior; Autistic Disorder, Current or Active State
Interventions: Procedure: Intravenous Bone Marrow Stem Cell (BMSC) Fraction; Procedure: Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction; Procedure: Near Infrared Light
Sponsor: MD Stem Cells
Recruiting
Interventions: Procedure: Intravenous Bone Marrow Stem Cell (BMSC) Fraction; Procedure: Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction; Procedure: Near Infrared Light
Sponsor: MD Stem Cells
Recruiting
